By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eli Lilly Canada Inc. 

3650 Danforth Avenue

Toronto  Ontario  M1N 2E8  Canada
Phone: 416-694-3221 Fax: 888-898-2961



Company News
Eli Lilly Canada Inc. (LLY) Release: Health Canada's Approval Of Taltz (Ixekizumab) Brings Targeted Therapy To Canadians Living With Moderate-To-Severe Plaque Psoriasis 6/21/2016 11:18:20 AM
Boehringer Ingelheim And Eli Lilly Canada Inc. (LLY) Release: Health Canada Approves JARDIANCE (empagliflozin) Tablets For Adults With Type 2 Diabetes 11/30/2015 6:22:02 AM
Health Canada Approves Eli Lilly Canada Inc. (LLY)'s Cymbalta for Knee Pain 11/8/2012 7:43:18 AM
Boehringer Ingelheim Corporation and Eli Lilly Canada Inc. (LLY) Present New linagliptin Data at American Diabetes Association's 72nd Scientific Sessions┬« 6/11/2012 11:00:59 AM
FDA Delays Approval of Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly Canada Inc. (LLY) (JOBS) Diabetes Drug; FDA Requests Finalization of Product Labeling 3/15/2010 6:39:30 AM
Eli Lilly Turns To Japan10/19/2005 5:13:07 PM
Eli Lilly and Company (LLY) Announces Important Liver Safety Update To Strattera(R) Label; Adds Warning10/19/2005 5:12:29 PM
Ranbaxy Laboratories Gains U.S. FDA Approval For Fluoxetine 40mg Capsules10/19/2005 5:12:28 PM
Eli Lilly and Company (LLY) Study Demonstrated Long-Term Treatment With Zyprexa(R) Reduced Violent Behavior In People With Schizophrenia Compared To Risperidone10/19/2005 5:12:28 PM
Eli Lilly and Company (LLY) Sets Date And Conference Call For Fourth-Quarter And Full-Year 2004 Earnings Announcement10/19/2005 5:12:26 PM